Yang Liu

Yang (Angela) Liu is an established CMC project team leader for an innovative portfolio at Pfizer, where they have held various roles, including Associate Research Fellow and Pharmaceutical Science Team Leader. Yang contributed significantly to the development and implementation of advanced process analytical technology (PAT) methods, gaining global approval for Daurismo in 2018. Prior to their tenure at Pfizer, Yang completed a postdoctoral research position in Chemometrics at the University of Delaware. They earned their Ph.D. in Analytical Chemistry from Wuhan University and a Master's degree in Chemical Engineering from Zhengzhou University.